PBH
Prestige Consumer Healthcare Inc.Healthcare · Drug Manufacturers - Specialty & Generic
$316.86 sample
+3.21 (+1.02%) 1D
Market cap
$444.9B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-19
Alerts
8
Price$316.86 +5.25% 3M daily closessample
318.24292.90
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral
Latest events
Filings, trades, FDA; newest first- Oct 19SEC
- Oct 08INS
- Sep 30INS
- Sep 21INS
- Sep 11INS
- Sep 07INS
- Aug 31INS
- Aug 25INS
Company facts
SEC EDGAR registration- Name
- Prestige Consumer Healthcare Inc.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Smart-money score
- -27sample, -100 to +100
- Reporting currency
- USD
Who is positioning in PBH
sample- Insiders
- 8 insider transactions over 90 days, net selling, $575.7M
- Congress
- 2 members traded over 90 days
- Institutions · 13F
- 28 funds hold $8.3B
- Activists · 13D/G
- No 13D/13G activist filings on record
How are the fundamentals trending?
sample, by period endRevenue$23.2B +15.1% y/y
Q4 2024Q3 2026
Inventory$13.8B +16.7% y/y
Q4 2024Q3 2026
Accounts receivable$10.1B +7.6% y/y
Q4 2024Q3 2026
Total debt$27.8B +8.0% y/y
Q4 2024Q3 2026
Peers
sample- Sample peer A
- $241.6B +11.3% 3M
- Sample peer B
- $228.1B -12.3% 3M
- Sample peer C
- $48.0B +10.2% 3M
- Sample peer D
- $273.8B +9.8% 3M
- Sample peer E
- $92.9B -9.5% 3M